Hodgkin's lymphoma.
Cole S, Dunne K.
Nurs Stand. 2004 Jan 21-27;18(19):46-52; quiz 54-5. doi: 10.7748/ns2004.01.18.19.46.c3531.
EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma.
Parekh V, Peker D.
J Clin Pathol. 2015 Nov;68(11):947-50. doi: 10.1136/jclinpath-2015-203145. Epub 2015 Jul 20.
Histopathology of Hodgkin's lymphoma.
Eberle FC, Mani H, Jaffe ES.
Cancer J. 2009 Mar-Apr;15(2):129-37. doi: 10.1097/PPO.0b013e31819e31cf.
[Lymphocyte-depleted classical Hodgkin lymphoma accompanied by myelofibrosis].
Sakatoku K, Takeoka Y, Araki T, Miura A, Fujitani Y, Yamamura R, Miyagi Y, Senzaki H, Ohta K.
Rinsho Ketsueki. 2017;58(7):772-775. doi: 10.11406/rinketsu.58.772.
[Hodgkin lymphoma].
Suzumiya J.
Rinsho Ketsueki. 2009 Apr;50(4):261-70.
Cytotoxic T-lymphocyte-associated 4 protein expression is associated with a high international prognostic score in advanced-stage classical Hodgkin lymphoma.
Pangaribuan FD, Ham MF, Mutmainnah M, Harahap AS.
BMC Res Notes. 2024 Jul 8;17(1):190. doi: 10.1186/s13104-024-06853-1.
Introduction to a review series on Hodgkin lymphoma: change is here.
Sehn LH.
Blood. 2018 Apr 12;131(15):1629-1630. doi: 10.1182/blood-2018-02-824045. Epub 2018 Mar 2.
Frequency of epstein-barr virus in classical hodgkin Lymphoma.
Azhar M, Din HU, Muhammad I, Hashmi SN, Akhtar F.
J Ayub Med Coll Abbottabad. 2016 Apr-Jun;28(2):271-275.
Treatment of lymphocyte-predominant Hodgkin lymphoma.
Engert A.
Ann Oncol. 2008 Jun;19 Suppl 4:iv45-6. doi: 10.1093/annonc/mdn194.
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, Zukerberg LR.
Leuk Lymphoma. 2009 Jun;50(6):937-43. doi: 10.1080/10428190902930488.
